Posttranscriptional stimulation of endothelial cell matrix metalloproteinases 2 and 1 by endothelioma cells

Experimental Cell Research

Volumn 258, Issue 2, 2000, Pages 384-394

  Taraboletti, Giulia ^a   Sonzogni, Laura ^a   Vergani, Veronica ^a   Hosseini, Ghamartaj ^d   Ceruti, Roberta ^a,c   Ghilardi, Carmen ^a   Bastone, Antonio ^b   Toschi, Elena ^e   Borsotti, Patrizia ^a   Scanziani, Eugenio ^c   Giavazzi, Raffaella ^e   Pepper, Michael S ^d   Stetler Stevenson, William G ^e   Bani, Maria Rosa ^a  

^a MARIO NEGRI INST PHARMACOL RES   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Angiogenesis; Endothelial cells; Endothelioma; Hemangioma; Matrix metalloproteinases; Proteases secretion

Indexed keywords

COLLAGENASE; GELATINASE A; MESSENGER RNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME ANALYSIS; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA ANALYSIS; VASCULAR TUMOR; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALIA;

EID: 0034255611     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2000.4936     Document Type: Article

References (40)

1. Crawford H. C., Matrisian L. M. Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Invasion Metastasis. 14:1995;234-245.
2. Woessner J. F. Jr. Matrix metalloproteinases and their inhibitor in connective tissue remodeling. FASEB J. 5:1991;2145-2154.
3. MacDougall J. R., Matrisian L. M. Contributions of tumor and stroma matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev. 14:1995;351-362.
4. Mignatti P., Tsuboi R., Robbins E., Rifkin D. B. In vitro angiogenesis on the human amniotic membrane: Requirement for basic fibroblast growth factor-induced proteinases. J. Cell Biol. 108:1989;671-682.
5. Kleiner D. E., Stetler-Stevenson W. G. Structural biochemistry and activation of matrix metalloproteases. Curr. Opin. Cell Biol. 5:1993;891-897.
6. Cornelius L. A., Nehring L. C., Roby J. D., Parks W. C., Welgus H. G. Human dermal microvascular endothelial cells produce matrix metalloproteinases in response to angiogenic factors and migration. J. Invest. Dermatol. 105:1995;170-176.
7. Hanemaaijer R., Koolwijk P., Le Clercq L., de Vree W. J. A., van Hinsbergh V. W. M. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Biochem. J. 296:1993;803-809.
8. Unemori E. N., Ferrara N., Bauer E. A., Amento E. P. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J. Cell. Physiol. 153:1992;557-562.
9. Pepper M. S., Belin D., Montesano R., Orci L., Vassalli J.-D. Transforming growth factor beta-1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J. Cell Biol. 111:1990;743-755.
10. Galardy R. E., Grobelny D., Foellmer H. G., Fernandez L. A. Inhibition of angiogenesis by matrix metalloprotease inhibitor N-[2R-2-(hydroxamidocarbonymethyl)-4-methylpentanoyl]-l-tryptophan methylamide. Cancer Res. 54:1994;4715-4718.
11. Johnson M. D., Kim H. R. C., Chesler L., Tsau-Wu G., Bouck N., Polverini P. J. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J. Cell. Physiol. 160:1994;194-202.
12. Takigawa M., Nishida Y., Suzuki F., Kishi J., Yamashita K., Hayakawa T. Induction of angiogenesis in chick yolk-sac membrane by polyamines and its inhibition by tissue inhibitors of metalloproteinases (TIMP and TIMP-2). Biochem. Biophys. Res. Commun. 171:1990;1264-1271.
13. Taraboletti G., Garofalo A., Belotti D., Drudis T., Borsotti P., Scanziani E., Brown P. D., Giavazzi R. Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases. J. Natl. Cancer Inst. 87:1995;293-298.
14. Auerbach W., Auerbach R. Angiogenesis inhibition: A review. Pharmacol. Ther. 63:1994;265-311.
15. Brown P. D., Giavazzi R. Matrix metalloproteinase inhibition: A review of anti-tumor activity. Ann. Oncol. 6:1995;967-974.
16. Williams R. L., Risau W., Zerwes H.-G., Drexler H., Aguzzi A., Wagner E. F. Endothelioma cells expressing the polyoma middle T oncogene induce hemangiomas by host cell recruitment. Cell. 57:1989;1053-1063.
17. Williams R. L., Courtneidge S. A., Wagner E. F. Embryonic lethalities and endothelial tumors in chimeric mice expressing polyoma virus middle T oncogene. Cell. 52:1988;121-131.
18. Taraboletti G., Belotti D., Dejana E., Mantovani A., Giavazzi R. Endothelial cell migration and invasiveness are induced by a soluble factor produced by murine endothelioma cells transformed by polyoma virus middle T oncogene. Cancer Res. 53:1993;3812-3816.
19. Montesano R., Pepper M. S., Möhle-Steinlein U., Risau W., Wagner E. F., Orci L. Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene. Cell. 62:1990;435-445.
20. Sabapathy K. T., Pepper M. S., Kiefer F., Möhle-Steinlein U., Tacchini-Cottier F., Fetka I., Breier G., Risau W., Carmeliet P., Montesano R., Wagner E. F. Polyoma middle T-induced vascular tumor formation: The role of the plasminogen activator/plasmin system. J. Cell Biol. 137:1997;953-963.
21. Brown P. D., Whittaker M. Matrix metalloproteinase inhibitors. Teicher B. A. Antiangiogenic Agents in Cancer Therapy. 1999;205-223 Humana Press, Totowa.
22. Garlanda C., Parravicini C., Sironi M., De Rossi M., Wainstok de Calmanovici R., Bussolino F., Colotta F., Mantovani A., Vecchi A. Progressive growth in immunodeficient mice and host cell recruitment by mouse endothelial cells transformed by polyoma middle T: Implications for the pathogenesis of opportunistic vascular tumors. Proc. Natl. Acad. Sci. USA. 91:1994;7291-7295.
23. Vecchi A., Garlanda C., Lampugnani M. G., Resnati M., Matteucci C., Stopacciaro A., Schnurch H., Risua W., Ruco L., Mantovani A., Dejana E. Monoclonal antibodies specific for endothelial cells of mouse blood vessels: Their application in the identification of adult and embryonic endothelium. Eur. J. Cell Biol. 63:1994;247-254.
24. Smith Templeton N., Brown P. D., Levy A. T., Margulies I. M. K., Liotta L. A., Stetler-Stevenson W. G. Cloning and characterization of human tumor cell interstitial collagenase. Cancer Res. 50:1990;5431-5437.
25. Sato H., Takino T., Okada Y., Cao J., Shinagawa A., Yamamoto E., Seiki M. A matrix metalloproteinase expressed on the surface of tumor cells. Nature. 370:1994;61-65.
26. Ray J. M., Stetler-Stevenson W. G. TIMP-2 expression modulates human melanoma cell adhesion and motility. Ann. N. Y. Acad. Sci. 732:1994;233-247.
27. Reponen P., Sahlberg C., Huhtala P., Hurskainen T., Thesleff I., Tryggvason K. Molecular cloning of murine 72-kDa type IV collagenase and its expression during mouse development. J. Biol. Chem. 267:1992;7856-7862.
28. Reponen P., Sahlberg C., Munaut C., Thesleff I., Tryggvason K. High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development. J. Cell Biol. 124:1994;1091-1102.
29. Edwards D. R., Waterhousa P., Holman M. L., Denhardt D. T. A growth-responsive gene (16C8) in normal mouse fibroblasts homologous to a human collagenase inhibitor with erythroid-potentiating activity: Evidence for inducible and constitutive transcripts. Nucleic Acids Res. 14:1986;8863-8878.
30. Shimizu S., Malik K., Sejima H., Kishi J., Hayakawa T., Koiwai O. Cloning and sequencing of the cDNA encoding a mouse tissue inhibitor of metalloproteinase-2. Gene. 114:1992;291-292.
31. Feinberg A. P., Volgestin B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 1:1983;6-13.
32. Krowczynska A. M., Coutts M., Makrides S., Brawerman G. The mouse homologue of the human acidic ribosomal phosphoprotein PO: A highly conserved polypeptide that is under translational control. Nucleic Acids Res. 17:1989;6108.
33. Takahashi K., Mulliken J. B., Kozakewich H. P. W., Rogers R. A., Folkman J., Ezekowitz R. A. B. Cellular markers that distinguish the phases of hemangiomas during infancy and childhood. J. Clin. Invest. 93:1994;2357-2364.
34. Bussolino F., De Rossi M., Sica A., Colotta F., Wang J. M., Bocchietto E., Padura I. M., Bosia A., Dejana E., Mantovani A. Murine endothelioma cell lines transformed by polyoma middle T oncogene as target for and producers of cytokines. J. Immunol. 147:1991;2122-2129.
35. Goetzl E. J., Banda M. J., Leppert D. Matrix metalloproteinases in immunity. J. Immunol. 156:1996;1-4.
36. Unemori E. N., Bouhana K. S., Werb Z. Vectorial secretion of extracellular matrix proteins, matrix-degrading proteinases, and tissue inhibitor of metalloproteinases by endothelial cells. J. Biol. Chem. 265:1990;445-451.
37. Menashi S., Vlodavski I., Ishai-Michaeli R., Legrand Y., Fridman R. The extracellular matrix produced by bovine corneal endothelial cells contains progelatinase A. FEBS Lett. 361:1995;61-64.
38. Swallow C. J., Murray M. P., Guillem J. G. Metastatic colorectal cancer cells induce matrix metalloproteinase release by human monocytes. Clin. Exp. Metastasis. 14:1996;3-11.
39. Nguyen M., Arkell J., Jackson C. J. Active and tissue inhibitor of matrix metalloproteinase-free gelatinase B accumulates within human microvascular endothelial vesicles. J. Biol. Chem. 273:1998;5400-5404.
40. Rosnoblet C., Vischer U. M., Gerard R. D., Irminger J.-C., Halban P. A., Kruithof E. K. O. Storage of tissue-type plasminogen activator in Weibel-Palade bodies of human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 19:1999;1796-1803.